... 1 Clinical Study of ARX788 at San Antonio Breast Cancer Symposium ... CLINICAL TRIALS BIOTECHNOLOGY HEALTH PHARMACEUTICAL SCIENCE ONCOLOGY.
News
- Ambrx Biopharma Inc. Presents Positive Data from Ongoing ACE-Breast-01 Phase 1 Clinical ...
- The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail ...
The stock was slipping 6.15% to $17.40 in premarket trading. Click here to access Benzinga's FDA Calendar. On The Radar. Clinical Readouts. San ...
- UTSA renames engineering school after former Valero CEO - San Antonio Report
The University of Texas at San Antonio will rename the College of Engineering ... Of the 508 students enrolled in the Department of Biomedical and ...
- Four Fresh-Faced Biopharmas Reel in Millions in Series A Funds | BioSpace
Data from Dr. Goodarzi's I-SPY 2 trial will be presented today at the San Antonio Breast Cancer Symposium in Texas.
- Former Valero CEO donates $20M to UTSA - San Antonio Express-News
With about 4,241 students, 120 faculty and 40 staff members, the college houses three departments; biomedical and chemical engineering, ...